risperidone has been researched along with latrepirdine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Beniashvili, AG; Lepilkina, TA; Morozova, MA; Rupchev, GE | 1 |
1 trial(s) available for risperidone and latrepirdine
| Article | Year |
|---|---|
Double-blind placebo-controlled randomized efficacy and safety trial of add-on treatment of dimebon plus risperidone in schizophrenic patients during transition from acute psychotic episode to remission.
Topics: Acute Disease; Adult; Antipsychotic Agents; Cognition Disorders; Drug Therapy, Combination; Humans; Indoles; Male; Middle Aged; Neuropsychological Tests; Nootropic Agents; Risperidone; Schizophrenia, Paranoid; Severity of Illness Index | 2012 |
1 other study(ies) available for risperidone and latrepirdine
| Article | Year |
|---|---|
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |